Stanley Liauw, MD

UChicago Faculty Physicians

Stanley Liauw, MD

Professor of Radiation and Cellular Oncology
Professor of Comprehensive Cancer Research Center

UChicago Faculty Physicians who provide services at UChicago Medicine Ingalls Memorial are not employees or agents of UChicago Medicine Ingalls Memorial.

Dr. Stanley Liauw serves as the Director of Clinical Operations and is the clinical lead for the genitourinary (GU) cancer program and the gastrointestinal (GI) cancer program within the Department of Radiation and Cellular Oncology at the University of Chicago. In the past 10 years on faculty, Dr. Liauw has developed research programs in these disease sites, with an interest in outcomes research and clinical trials. The central mission of his research is to conduct clinical studies to define current clinical outcomes and areas of need, develop hypotheses, and test novel regimens to reduce the morbidity or mortality of radiation therapy in the treatment of cancer.

A major focus of Dr. Liauw's efforts include the periodic analysis and reporting of cancer outcomes with radiation therapy. This work, derived from multiple institutional databases of more than 2000 patients, has resulted in numerous abstract presentations and publications in peer-reviewed journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology, Biology, Physics and Cancer. These contributions generally fall into 3 categories of interest: presenting hypotheses to improve the therapeutic ratio of therapy, studying the use of imaging in radiation oncology, and exploring potential markers of response to therapy.

A number of clinical protocols have been opened for patients with genitourinary and gastrointestinal cancers. Dr. Liauw has investigated and initiated trials for a: phase I study of dose escalated stereotactic body RT trial for unresectable pancreatic cancer, phase II quality of life study of oral hormonal therapy with RT for prostate cancer, phase I study for oligometastatic renal cell cancer, and phase I randomized study for hepatocellular carcinoma treated with RT and immunotherapy.

Outside of his research interests, Dr. Liauw has overseen several intradepartmental projects aimed at improving clinical workflow and patient safety, with potential downstream effects on patient and employee satisfaction. He served as the clinical lead for the implementation of intraoperative radiation therapy in 2015, as an Associate Editor for GI cancers for the International Journal of Radiation Oncology, Biology, and Physics, as an examiner and question writer for the American Board of Radiology for GU cancers, and an invited speaker for national and international educational lectures such as through the American Society of Radiation Oncology (ASTRO) and the American Urological Association. He has been an invited Visiting Professor for resident education at multiple institutions, and has been regularly recognized from the University of Chicago training program as a top educator. He has been an ad hoc reviewer of manuscripts for more than 20 scientific journals, including Journal of Clinical Oncology and the New England Journal of Medicine.

Specialties

Areas of Expertise

Board Certifications

  • Radiation Oncology

Memberships & Medical Societies

  • American Society for Radiation Oncology

Practicing Since

  • 2006

Languages Spoken

  • English

Medical Education

  • University of Texas Southwestern; University of Texas Southwestern Medical School

Internship

  • Brigham and Women's Hospital

Residency

  • University of Florida; UF Heatlh Shands Hospital

News & Research

View Published Papers
  • Aetna HMO (specialists only)
  • Aetna POS
  • Aetna PPO
  • BCBS Blue Precision HMO (specialists only)
  • BCBS HMO (HMOI) (specialists only)
  • BCBS PPO
  • Cigna HMO
  • Cigna POS
  • Cigna PPO
  • CountyCare *see insurance page
  • Aetna Better Health *see insurance page
  • Medicare
  • Multiplan PPO
  • PHCS PPO
  • United Choice Plus POS/PPO
  • United Options (PPO)
  • United Select (HMO & EPO) (specialists only)
  • United W500 Emergent Wrap
  • Aetna Medicare Advantage HMO & PPO
  • BCBS Medicare Advantage HMO & PPO
  • Humana Medicare Advantage Choice PPO
  • Humana Medicare Advantage Gold Choice PFFS
  • Humana Medicare Advantage Gold Plus HMO
  • United Choice HMO (specialists only)
  • University of Chicago Health Plan (UCHP)

Our list of accepted insurance providers is subject to change at any time. You should contact your insurance company to confirm UChicago Medicine participates in their network before scheduling your appointment. If your insurance company is not listed here, or if you have any other questions, please contact Managed.Care@uchospitals.edu.

15 Reviews

View More Reviews
About Our Star Ratings and Comments:

Randomly selected patients are sent patient satisfaction surveys after their visits. We get thousands of survey responses each year. The responses are used to improve patient experience and recognize staff members for the care they provide. Patient survey responses are also used to make star ratings for each provider.

For the star ratings and comments, all feedback on the provider web page is posted as it was given from patients. Comments that do not apply, risk patient privacy, or are not appropriate are not posted. Star ratings and comments come from a number of survey questions. A star rating is not given if a provider only has a small number of survey responses.

Duchossois Center for Advanced Medicine (DCAM) - Hyde Park

Request an Appointment at Duchossois Center for Advanced Medicine (DCAM) - Hyde Park

To Refer a Patient

Refer a Patient
Prostate Cancer Q & A

UChicago Medicine prostate cancer experts answer questions about the latest prostate cancer treatments, hereditary factors that increase the risk for prostate cancer and advanced research under way to improve the diagnosis and treatment of prostate cancer. 

Watch Video